Novel SARS-CoV-2 Omicron variants in İstanbul; Rapid Preponderance of BA.2 and BA.5.

Infectious diseases & clinical microbiology Pub Date : 2022-09-26 eCollection Date: 2022-09-01 DOI:10.36519/idcm.2022.143
Yeşim Tuyji-Tok, Ebru Yücebağ, Ayşe Betül Keleş, Ayşe Ceylan Kılınçarslan, Okan Kadir Nohut, Seda Salman-Yılmaz, Mert Ahmet Kuşkucu, Kenan Midilli
{"title":"Novel SARS-CoV-2 Omicron variants in İstanbul; Rapid Preponderance of BA.2 and BA.5.","authors":"Yeşim Tuyji-Tok, Ebru Yücebağ, Ayşe Betül Keleş, Ayşe Ceylan Kılınçarslan, Okan Kadir Nohut, Seda Salman-Yılmaz, Mert Ahmet Kuşkucu, Kenan Midilli","doi":"10.36519/idcm.2022.143","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>In Turkey, the fourth wave of SARS-CoV-2 started in December 2021 and peaked in mid-January 2022. Afterward, peaks were seen in the number of COVID-19 cases because of Omicron BA.2 and BA.5 variants. Our study aimed to observe the prevalence and viral load-related transmissibility rates of the Omicron BA.2 and BA.5 variant infections in our region between January 21 and July 01, 2022, using an easy and cost-effective PCR screening method.</p><p><strong>Methods: </strong>The frequency of BA.2 and BA.5 were determined by the two-stage allele-specific and drop-out RT-PCR method targeting NSP6 105-107del, spike 69-70del, and spike L452R mutation-specific primers. Transmissibility of the Omicron variants was assessed using cycle threshold (Ct) values (a proxy for SARS-CoV-2 viral load and infectivity). Also, using the next generation sequencing (NGS) method, existing mutations were analyzed by generating full-length sequences of the representative, randomly selected samples from the Omicron variants determined by PCR screening test.</p><p><strong>Results: </strong>We defined the first case of BA.2 on January 19, 2022, in İstanbul University-Cerrahpaşa School of Medicine COVID-19 Molecular Diagnosis Laboratory. Following this, it was observed that BA.1 lost its dominance due to the increased transmissibility of BA.2. On May 5, we defined the first case of BA.5, and as of July this Omicron variant rapidly became preponderant, with a frequency of more than 85%. Compared with BA.1, BA.2 and BA.5 were associated with 2.82 (95% CI: 2.33-4.12) and 2.49 (95% CI: 2.16-3.55) fewer cycles, respectively, meaning higher transmissibility. As confirmed by the NGS results, it was concluded that screening with NSP6 105-107del, spike 69-70del and spike L452R mutation targeted PCR method, which is used uniquely in our hospital in Turkey, can be an easy and cost-effective method in the follow-up of Omicron variants.</p><p><strong>Conclusion: </strong>The higher viral load detection in infections with BA.2 and BA.5 reflects a prolonged disease period, and increased transmissibility, so rapid expansion of these Omicron variants in Turkey is inevitable. Even though the prevalence of the Omicron variants in the population can be monitored in near real-time by the PCR screening method, more sequencing studies are needed for the early identification of new mutations that will emerge.</p>","PeriodicalId":519881,"journal":{"name":"Infectious diseases & clinical microbiology","volume":"4 3","pages":"192-198"},"PeriodicalIF":0.0000,"publicationDate":"2022-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10985815/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Infectious diseases & clinical microbiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.36519/idcm.2022.143","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/9/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: In Turkey, the fourth wave of SARS-CoV-2 started in December 2021 and peaked in mid-January 2022. Afterward, peaks were seen in the number of COVID-19 cases because of Omicron BA.2 and BA.5 variants. Our study aimed to observe the prevalence and viral load-related transmissibility rates of the Omicron BA.2 and BA.5 variant infections in our region between January 21 and July 01, 2022, using an easy and cost-effective PCR screening method.

Methods: The frequency of BA.2 and BA.5 were determined by the two-stage allele-specific and drop-out RT-PCR method targeting NSP6 105-107del, spike 69-70del, and spike L452R mutation-specific primers. Transmissibility of the Omicron variants was assessed using cycle threshold (Ct) values (a proxy for SARS-CoV-2 viral load and infectivity). Also, using the next generation sequencing (NGS) method, existing mutations were analyzed by generating full-length sequences of the representative, randomly selected samples from the Omicron variants determined by PCR screening test.

Results: We defined the first case of BA.2 on January 19, 2022, in İstanbul University-Cerrahpaşa School of Medicine COVID-19 Molecular Diagnosis Laboratory. Following this, it was observed that BA.1 lost its dominance due to the increased transmissibility of BA.2. On May 5, we defined the first case of BA.5, and as of July this Omicron variant rapidly became preponderant, with a frequency of more than 85%. Compared with BA.1, BA.2 and BA.5 were associated with 2.82 (95% CI: 2.33-4.12) and 2.49 (95% CI: 2.16-3.55) fewer cycles, respectively, meaning higher transmissibility. As confirmed by the NGS results, it was concluded that screening with NSP6 105-107del, spike 69-70del and spike L452R mutation targeted PCR method, which is used uniquely in our hospital in Turkey, can be an easy and cost-effective method in the follow-up of Omicron variants.

Conclusion: The higher viral load detection in infections with BA.2 and BA.5 reflects a prolonged disease period, and increased transmissibility, so rapid expansion of these Omicron variants in Turkey is inevitable. Even though the prevalence of the Omicron variants in the population can be monitored in near real-time by the PCR screening method, more sequencing studies are needed for the early identification of new mutations that will emerge.

伊斯坦布尔的新型 SARS-CoV-2 Omicron 变体;BA.2 和 BA.5 的快速优势。
目的:在土耳其,SARS-CoV-2 的第四波于 2021 年 12 月开始,并于 2022 年 1 月中旬达到高峰。之后,由于出现了 Omicron BA.2 和 BA.5 变体,COVID-19 病例数也达到了高峰。我们的研究旨在采用简便、经济的 PCR 筛查方法,观察 2022 年 1 月 21 日至 7 月 1 日期间本地区奥米克龙 BA.2 和 BA.5 变体感染的流行率和与病毒载量相关的传播率:方法:采用针对NSP6 105-107del、spike 69-70del和spike L452R突变特异性引物的两阶段等位基因特异性和脱落RT-PCR方法测定BA.2和BA.5的频率。使用周期阈值(Ct)(SARS-CoV-2 病毒载量和感染性的替代指标)评估了 Omicron 变体的传播性。此外,我们还使用下一代测序(NGS)方法,从通过 PCR 筛选测试确定的 Omicron 变体中随机抽取的代表性样本中生成全长序列,对现有的突变进行了分析:我们于 2022 年 1 月 19 日在伊斯坦布尔大学切拉帕萨医学院 COVID-19 分子诊断实验室确定了首例 BA.2 病例。在此之后,我们观察到 BA.1 因 BA.2 的传播性增加而失去了主导地位。5 月 5 日,我们确定了第一例 BA.5,从 7 月起,这种欧米克隆变异体迅速成为主要变异体,频率超过 85%。与 BA.1 相比,BA.2 和 BA.5 的传播周期分别减少了 2.82(95% CI:2.33-4.12)和 2.49(95% CI:2.16-3.55)个,这意味着传播率更高。正如 NGS 结果所证实的那样,使用 NSP6 105-107del、spike 69-70del 和 spike L452R 突变靶向 PCR 方法进行筛查是一种简便且经济有效的奥米克龙变异体随访方法:BA.2和BA.5感染者的病毒载量检测率较高,这反映出他们的病程较长,传播能力较强,因此这些奥米克龙变异体在土耳其的迅速扩展是不可避免的。尽管可以通过 PCR 筛查方法近乎实时地监测奥米克龙变异体在人群中的流行情况,但仍需要进行更多的测序研究,以便及早发现即将出现的新变异体。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信